Glossary
To search for a
particular term, go to Edit > Find at the top of your browser and
type in the term you're looking for.
Addiction.
A chronic, relapsing disease characterized by compulsive drug-seeking
and use and by neurochemical and molecular changes in the brain; sometimes
used synonymously with "dependence."
Addictive
Personality. A common belief that particular personality traits
predispose to addiction to drugs, sex, eating, etc. There is no scientific
support for this belief.
Anxiolytic.
A medication used to reduce anxiety symptoms; also known as tranquilizer
or anti-anxiety medication.
Aversive
Smoking. Several types of therapeutic techniques that involve
smoking in an unpleasant or concentrated manner. These techniques pair
smoking with negative associations or responses. Notable examples include
rapid smoking, rapid puffing, focused smoking, and satiation smoking.
Buerger's
Disease. A disease of the arteries and veins characterized
by pain, color changes, and coldness in the fingers and toes; results
from thickening of the walls of blood vessels. Smoking worsens Buerger's
disease.
Bupropion.
A non-nicotine prescription medication used both for smoking cessation
(Zyban) and for treating depression (Wellbutrin).
Carbon Monoxide.
Carbon monoxide (CO) is a colorless, odorless, poisonous gas produced
by the burning of tobacco. CO binds more readily to hemoglobin than
oxygen, thereby reducing the oxygen-carrying capacity of the blood.
Carcinogen.
A chemical or other substance that causes cancer; tobacco smoke has
more than 40 known carcinogens.
Chewing
Tobacco. A type of smokeless tobacco that is potentially addictive
because it contains nicotine. Longterm, regular use can cause oral cancers
and dental problems; it should not be used as a substitute for smoking
cigarettes. Also known as spit tobacco, chew, dip, and chaw.
Chipper.
Smokers who smoke at a low rate, e.g., 1-5 cigarettes per day. An estimated
10-20% of all smokers are chippers. Also know as social smoker or a
periodic smoker.
Chronic
Obstructive Pulmonary Disease (COPD) is a lung disease in which
the airways in the lungs produce excess mucus resulting in frequent
coughing. Smoking accounts for 80% to 90% of the risk for developing
COPD.
Clinician.
A professional directly providing health care services.
Clonidine.
A prescription medication (Catapres; generic available) primarily used
to lower blood pressure. It has also been shown in research studies
to help smokers quit smoking. Not approved by the FDA for smoking cessation.
Cognitive-Behavioral
Therapy (CBT). A psychotherapeutic approach aimed at identifying
and modifying faulty or distorted negative thinking styles and the maladaptive
behaviors associated with those thinking styles.
Cold Turkey.
A smoking cessation strategy that involves abrupt cessation of smoking.
Used alone, only 5% to 7% of smokers will remain abstinent long-term.
Compensatory
Smoking. When a smoker inhales more smoke, or smokes more intensely,
to compensate for reductions in nicotine content of tobacco smoke or
number of cigarettes smoked per day.
COPD.
Chronic Obstructive Pulmonary Disease (COPD) is a lung
disease in which the airways in the lungs produce excess mucus resulting
in frequent coughing. Smoking accounts for 80% to 90% of the risk for
developing COPD.
Coronary
Artery Disease. Thickening of the coronary arteries due to
buildup of plaque (fatty deposits); causes narrowing of the arteries
so that the supply of blood and oxygen to the heart is restricted or
blocked. Smoking is a major risk factor for coronary artery disease.
Cotinine.
Cotinine is nicotine's major metabolite, which has a significantly longer
half-life than nicotine. Cotinine measurement is often used to estimate
a patient's tobacco/nicotine usage prior to quitting, and to confirm
abstinence self-reports during follow-up. Cotinine is commonly measured
in serum, urine, and saliva.
Craving.
A powerful, often uncontrollable, desire.
Dependence.
A chronic, relapsing disease characterized by compulsive drug-seeking
and use and by neurochemical and molecular changes in the brain. "Dependence"
is sometimes used synonymously with "addiction;" a psychiatric
diagnosis described in the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition (1994).
Depression.
A psychiatric disorder characterized by sad mood, loss of pleasure,
guilt, disturbed sleep and appetite, and/or self-blame lasting two weeks
or more. Previously depressed smokers are half as likely to be able
to quit smoking without specialized treatment.
Dopamine.
A neurotransmitter present in regions of the brain that regulate movement,
emotion, motivation, and the feeling of pleasure.
Emphysema.
An irreversible chronic lung disease in which the alveoli (small air
sacs in the lung) become damaged; smoking is the most common cause of
emphysema.
Environmental
Tobacco Smoke (ETS). Also known as secondhand smoke or passive
smoking; occurs when people inhale the smoke of others. ETS contains
the same harmful chemicals that smokers inhale.
Epidemiology.
The study of factors that influence the frequency and distribution of
diseases, such as cancer, in an effort to find the cause and therefore
prevent them. For instance cancer epidemiology studies how physical
surroundings, occupational hazards and personal habits (diet, smoking,
lifestyle) may contribute to the development of cancer.
Fading.
Cigarette fading (or smoking reduction) involves reducing the number
of cigarettes smoked prior to quitting smoking.
Focused
Smoking. A smoking cessation technique in which a smoker sits
facing a blank wall, smoking at a normal rate while being told by a
cessation counselor to focus on the bad aspects of smoking (e.g., bad
taste, burning in the throat, nausea, etc.).
Lapse.
A brief, temporary resumption of smoking, perhaps a few cigarettes,
after a cessation attempt; synonymous with "slip."
Mainstream
Smoke. Smoke that is exhaled by a smoker (in contrast to "sidestream
smoke" that comes from a burning cigarette).
Managed
Care Organizations (MCO). Any group implementing health care
using managed care concepts including pre-authorization of treatment,
utilization review, and a fixed network of providers.
Mean.
A statistical measurement of the central tendency or average of a set
of values.
Menthol.
A chemical added to cigarettes to produce a cool sensation in the throat
when smoke is inhaled.
Neurotransmitter.
Chemical messengers in the nervous system that permit nerve cells to
communicate; examples include dopamine, serotonin, and norepinephrine.
Nicotine acts on several neurotransmitters including acetylcholine and
dopamine.
Nicotine.
An alkaloid (chemical substance) derived from the tobacco plant that
is responsible for smoking's psychoactive and addictive effects. It
is toxic at high doses but can be safe and effective as a medicine at
lower doses.
Nicotine
Gum. Nicotine-containing gum that delivers nicotine through
the lining of the mouth. It is available without a prescription, marketed
as Nicorette.
Nicotine
Inhaler. Nicotine-containing inhaler that delivers nicotine
in a vapor that is absorbed in the mouth. It is available by prescription
only, marketed as the Nicotrol Inhaler.
Nicotine
Nasal Spray. Nicotine-containing nasal spray that delivers
nicotine in a mist that is absorbed in the nasal passages. It is available
by prescription only, marketed as Nicotrol Nasal Spray.
Nicotine
Patch. A nicotine-containing patch that delivers nicotine through
the skin; available without a prescription. Brands include Nicoderm,
Habitrol, Nicotrol, and ProStep. Generics may be available.
Nicotine
Replacement Therapy (NRT). Nicotine-containing medications
used for smoking cessation including the nicotine patch, nicotine gum,
nicotine inhaler, and nicotine nasal spray.
Nortriptyline.
An antidepressant that has been found in research studies to be potentially
effective for smoking cessation; however, the Food and Drug Administration
has not approved nortriptyline as a smoking cessation aid.
Pharmacotherapy.
Treatment that uses one or more medications. Five medications are FDA-approved
for smoking cessation: nicotine gum, nicotine patch, nicotine inhaler,
nicotine nasal spray, and Zyban (buproprion SR).
Physical
Dependence. An adaptive physiological state that occurs with
regular drug use and results in a withdrawal syndrome when drug use
is stopped.
Placebo.
An inactive, harmless substance with no direct beneficial effects. Usually
used in clinical studies for comparison to measure the effectiveness
of an experimental drug or regimen.
Prevalence.
Total number of persons in a given population with a disease or other
health-related event during a specified period of time, usually expressed
as a percentage. The prevalence of smoking in U.S adults is approximately
25%.
Problem
Solving/Skills Training. Refers to a tobacco use treatment
in which tobacco users are trained to identify and cope with events
or problems that increase the likelihood of their using tobacco. For
example, quitters might be trained to anticipate stressful events and
to use coping skills such as distraction or deep breathing to cope with
an urge to smoke.
Psychoactive.
A chemical substance that exerts psychological effects including changes
in mood, cognition, and behavior. Nicotine is a psychoactive drug.
Pulmonary
Function Test. A specialized lung test that takes about 10
minutes and requires that the patient blow big breaths into a machine;
this test helps the doctor evaluate the health status of the patient's
lungs.
Randomized
Controlled Trial. A study in which subjects are assigned to
conditions on the basis of chance and where at least one of the conditions
is a control or a comparison condition (e.g., where a placebo is given).
Rapid Puffing/Smoking.
A smoking cessation technique that involves pairing smoking in a concentrated
manner with negative associations or responses (e.g., nausea). This
technique should only be used by a trained professional in consultation
with a medical doctor.
Raynaud
Disease. Temporary discoloration, mild tingling/numbness, and
sometimes pain of the fingers and toes due to reduced blood flow and
reduced availability of oxygen. It occurs in response to changes in
temperature and emotional events. Smoking can trigger episodes of Raynaud
Disease.
Relapse.
A return to regular smoking after a cessation attempt.
Risk Factors.
Conditions that increase a person's chances of getting a disease (such
as cancer). Risk factors do not cause the disease, rather they indicate
that a person has a higher chance of getting the disease.
Secondhand
Smoke. Also known as environmental tobacco smoke (ETS). The
smoke inhaled by an individual not actively engaged in smoking. It contains
the same harmful chemicals that smokers inhale.
Sidestream
Smoke. Smoke that comes from a lit or smoldering cigarette
(in contrast to "mainstream smoke" that is exhaled by a smoker).
SIDS.
Sudden Infant Death Syndrome (SIDS or crib death) is
the leading cause of death for U.S. infants over one month of age. Smoking
by a mother or a father doubles the risk (or worse) that the baby will
die from SIDS; the risk increases with heavier smoking.
Silver Acetate.
Silver acetate is a chemical compound that reacts with cigarette smoke
to produce an unpleasant taste and has been investigated as a deterrent
to smoking. Scientific studies have shown no support for silver acetate
as a treatment for smoking cessation.
Smokeless
Tobacco. Includes snuff and chewing tobacco; not a safe alternative
to smoking. Smokeless tobacco is as addictive as smoking and can cause
cancer of the gum, cheek, lip, mouth, tongue, and throat.
Smoker's
Cough. The chronic cough experienced by smokers because smoking
impairs the lung's ability to clean out harmful material. Coughing is
the body's way of trying to get rid of the harmful material in the lungs.
Snuff.
Smokeless tobacco that consists of cured, finely-ground tobacco marketed
in various forms (e.g., dry, moist, fine cut). Users put a pinch (dip)
of snuff between gum and lip (or cheek) or snort snuff into the nose
where nicotine is absorbed.
Tar.
An oily substance resulting from the burning of tobacco and consisting
of thousands of chemicals, some of which are carcinogenic or otherwise
harmful,
Teratogen.
A chemical or biological agent capable of causing malformations in embryos;
a well-known example is thalidomide. Many of the chemicals in tobacco
smoke are known teratogens.
Thiocyanate.
A biochemical substance that is produced by smoking tobacco; sometimes
as an indicator of smoking in smoking cessation studies and treatment
programs.
Tolerance.
A condition in which higher doses of a drug are required to produce
the same effect as during initial drug use. Tolerance often leads to
physical dependence.
Transdermal
Nicotine. Also known as the nicotine patch; smoking cessation
medication that delivers nicotine by diffusion through the skin.
Transdisciplinary Research. Pertaining to or involving more than one type, field or segment of scientific study.
Trigger.
Situations, thoughts, or feelings that "trigger" the urge
to smoke. Common triggers include stressful events, driving in the car,
drinking alcohol, watching TV, negative emotions, and breaks from work.
Urge.
In smokers, an "urge" is a desire to smoke that can vary in
intensity from mild to very strong. Some urges are strong enough that
a recently quit smoker may experience a lapse or relapse.
Withdrawal.
A variety of unpleasant symptoms (e.g., difficulty concentrating, irritability,
anxiety, anger, depressed mood, sleep disturbance, and craving) that
occur after use of an addictive drug is reduced or stopped. Withdrawal
symptoms are thought to increase the risk for relapse.
Zyban.
A prescription smoking cessation medication that contains bupropion
in a sustained-release formulation.
|